Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza.

Trial Profile

Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jul 2013

At a glance

  • Drugs DAS 181 (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 16 Aug 2011 Status changed from active, no longer recruiting to completed, as reported in a NexBio media release.
    • 15 Aug 2011 Topline data reported in a NexBio media release, and will also be presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy in September 2011.
    • 05 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top